Luke EVNIN

Person

San Francisco, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Constrained conditionally activated binding proteins
- Patent number 12,128,102
- Issue date Oct 29, 2024
- Takeda Pharmaceutical Company Limited
- Patrick Baeuerle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Trispecific binding proteins and methods of use
- Patent number 12,084,518
- Issue date Sep 10, 2024
- HARPOON THERAPEUTICS, INC.
- Patrick Baeuerle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Activatable interleukin-2 polypeptides and methods of use thereof
- Patent number 11,981,716
- Issue date May 14, 2024
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of using bispecific CD33 and CD3 binding proteins
- Patent number 11,753,469
- Issue date Sep 12, 2023
- Anji Bruno, LLC
- Luke Evnin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Separation moieties and methods of use thereof
- Patent number 11,739,132
- Issue date Aug 29, 2023
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Single chain variable fragment CD3 binding proteins
- Patent number 11,623,958
- Issue date Apr 11, 2023
- HARPOON THERAPEUTICS, INC.
- Robert B. Dubridge
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Activatable interleukin-2 polypeptides and methods of use thereof
- Patent number 11,535,658
- Issue date Dec 27, 2022
- Werewolf Therapeutics, Inc.
- William Winston
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Activatable interleukin 12 polypeptides and methods of use thereof
- Patent number 11,453,710
- Issue date Sep 27, 2022
- Werewolf Therapeutics, Inc.
- William Winston
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Single domain serum albumin binding protein
- Patent number 11,453,716
- Issue date Sep 27, 2022
- HARPOON THERAPEUTICS, INC.
- Robert B. Dubridge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Activatable interleukin-2 polypeptides and methods of use thereof
- Patent number 11,352,403
- Issue date Jun 7, 2022
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Trispecific binding proteins and methods of use
- Patent number 10,954,311
- Issue date Mar 23, 2021
- HARPOON THERAPEUTICS, INC.
- Patrick Baeuerle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of using bispecific CD33 and CD3 binding proteins
- Patent number 10,738,118
- Issue date Aug 11, 2020
- Amphivena Therapeutics, Inc.
- Luke Evnin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Activatable interleukin-2 polypeptides
- Patent number 10,696,724
- Issue date Jun 30, 2020
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Activatable interleukin 12 polypeptides
- Patent number 10,696,723
- Issue date Jun 30, 2020
- Werewolf Therapeutics, Inc.
- William Winston
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific CD33 and CD3 binding proteins
- Patent number 10,626,190
- Issue date Apr 21, 2020
- Amphivena Therapeutics, Inc.
- Kristina Ellwanger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Single chain variable fragment CD3 binding proteins
- Patent number 10,544,221
- Issue date Jan 28, 2020
- HARPOON THERAPEUTICS, INC.
- Robert B. Dubridge
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Single domain serum albumin binding protein
- Patent number 10,100,106
- Issue date Oct 16, 2018
- HARPOON THERAPEUTICS, INC.
- Robert B. Dubridge
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Single chain variable fragment CD3 binding proteins
- Patent number 10,066,016
- Issue date Sep 4, 2018
- HARPOON THERAPEUTICS, INC.
- Robert B. Dubridge
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Single domain serum albumin binding protein
- Patent number 9,920,115
- Issue date Mar 20, 2018
- Robert B. Dubridge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific CD33 and CD3 binding proteins
- Patent number 9,803,029
- Issue date Oct 31, 2017
- AMPHIVENA THERAPEUTICS, INC.
- Kristina Ellwanger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Trispecific binding proteins and methods of use
- Patent number 9,708,412
- Issue date Jul 18, 2017
- HARPOON THERAPEUTICS, INC.
- Patrick Baeuerle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific CD33 and CD3 binding proteins
- Patent number 9,212,225
- Issue date Dec 15, 2015
- AMPHIVENA THERAPEUTICS, INC.
- Kristina Ellwanger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
SINGLE CHAIN VARIABLE FRAGMENT CD3 BINDING PROTEINS
- Publication number 20240084009
- Publication date Mar 14, 2024
- Harpoon Therapeutics, Inc.
- Robert B. DUBRIDGE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20230374093
- Publication date Nov 23, 2023
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SEPARATION MOIETIES AND METHODS OF USE THEREOF
- Publication number 20230272028
- Publication date Aug 31, 2023
- Werewolf Therapeutics, Inc.
- William WINSTON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SINGLE DOMAIN SERUM ALBUMIN BINDING PROTEIN
- Publication number 20230257451
- Publication date Aug 17, 2023
- Harpoon Therapeutics, Inc.
- Robert B. DUBRIDGE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ACTIVATABLE INTERLEUKIN 12 POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20220324930
- Publication date Oct 13, 2022
- Werewolf Therapeutics, Inc.
- William Winston
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SEPARATION MOIETIES AND METHODS OF USE THEREOF
- Publication number 20220220181
- Publication date Jul 14, 2022
- Werewolf Therapeutics, Inc.
- William WINSTON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20220056096
- Publication date Feb 24, 2022
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20210403524
- Publication date Dec 30, 2021
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRISPECIFIC BINDING PROTEINS AND METHODS OF USE
- Publication number 20210179735
- Publication date Jun 17, 2021
- Harpoon Therapeutics, Inc.
- Patrick BAEUERLE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SEPARATION MOIETIES AND METHODS OF USE THEREOF
- Publication number 20210115102
- Publication date Apr 22, 2021
- Werewolf Therapeutics, Inc.
- William WINSTON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods of Using Bispecific CD33 and CD3 Binding Proteins
- Publication number 20210032339
- Publication date Feb 4, 2021
- Amphivena Therapeutics, Inc.
- Luke Evnin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bispecific CD33 and CD3 Binding Proteins
- Publication number 20210024654
- Publication date Jan 28, 2021
- Amphivena Therapeutics, Inc.
- Kristina ELLWANGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20200283490
- Publication date Sep 10, 2020
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE INTERLEUKIN 12 POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20200283489
- Publication date Sep 10, 2020
- Werewolf Therapeutics, Inc.
- William Winston
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SINGLE CHAIN VARIABLE FRAGMENT CD3 BINDING PROTEINS
- Publication number 20200231672
- Publication date Jul 23, 2020
- Harpoon Therapeutics, Inc.
- Robert B. DUBRIDGE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS FOR ADOPTIVE CELL THERAPIES
- Publication number 20200115461
- Publication date Apr 16, 2020
- Harpoon Therapeutics, Inc.
- Luke EVNIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20200040052
- Publication date Feb 6, 2020
- Werewolf Therapeutics, Inc.
- William WINSTON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE INTERLEUKIN 12 POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20190367576
- Publication date Dec 5, 2019
- Werewolf Therapeutics, Inc.
- William WINSTON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INNATE IMMUNE CELL TRISPECIFIC BINDING PROTEINS AND METHODS OF USE
- Publication number 20190225702
- Publication date Jul 25, 2019
- Harpoon Therapeutics, Inc.
- Patrick BAEUERLE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SINGLE DOMAIN SERUM ALBUMIN BINDING PROTEIN
- Publication number 20190031749
- Publication date Jan 31, 2019
- Harpoon Therapeutics, Inc.
- Robert B. DUBRIDGE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bispecific CD33 and CD3 Binding Proteins
- Publication number 20180291113
- Publication date Oct 11, 2018
- Amphivena Therapeutics, Inc.
- Kristina ELLWANGER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF USING BISPECIFIC CD33 AND CD3 BINDING PROTEINS
- Publication number 20180148507
- Publication date May 31, 2018
- Amphivena Therapeutics, Inc.
- Luke EVNIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INDUCIBLE BINDING PROTEINS AND METHODS OF USE
- Publication number 20180134789
- Publication date May 17, 2018
- MAVERICK THERAPEUTICS, INC.
- Patrick BAEUERLE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SINGLE DOMAIN SERUM ALBUMIN BINDING PROTEIN
- Publication number 20170369563
- Publication date Dec 28, 2017
- Harpoon Therapeutics, Inc.
- Robert B. DUBRIDGE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SINGLE CHAIN VARIABLE FRAGMENT CD3 BINDING PROTEINS
- Publication number 20170369575
- Publication date Dec 28, 2017
- Harpoon Therapeutics, Inc.
- Robert B. DUBRIDGE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SINGLE CHAIN VARIABLE FRAGMENT CD3 BINDING PROTEINS
- Publication number 20170334997
- Publication date Nov 23, 2017
- Harpoon Therapeutics, Inc.
- Robert B. DUBRIDGE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SINGLE DOMAIN SERUM ALBUMIN BINDING PROTEIN
- Publication number 20170334979
- Publication date Nov 23, 2017
- Harpoon Therapeutics, Inc.
- Robert B. DUBRIDGE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRISPECIFIC BINDING PROTEINS AND METHODS OF USE
- Publication number 20170298149
- Publication date Oct 19, 2017
- Harpoon Therapeutics, Inc.
- Patrick BAEUERLE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRISPECIFIC BINDING PROTEINS AND METHODS OF USE
- Publication number 20160340444
- Publication date Nov 24, 2016
- Harpoon Therapeutics, Inc.
- Patrick BAEUERLE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bispecific CD33 and CD3 Binding Proteins
- Publication number 20160194409
- Publication date Jul 7, 2016
- Amphivena Therapeutics, Inc.
- Kristina ELLWANGER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Person

Patents Grantslast 30 patents

Constrained conditionally activated binding proteins

Trispecific binding proteins and methods of use

Activatable interleukin-2 polypeptides and methods of use thereof

Methods of using bispecific CD33 and CD3 binding proteins

Separation moieties and methods of use thereof

Single chain variable fragment CD3 binding proteins

Activatable interleukin-2 polypeptides and methods of use thereof

Activatable interleukin 12 polypeptides and methods of use thereof

Single domain serum albumin binding protein

Activatable interleukin-2 polypeptides and methods of use thereof

Trispecific binding proteins and methods of use

Methods of using bispecific CD33 and CD3 binding proteins

Activatable interleukin-2 polypeptides

Activatable interleukin 12 polypeptides

Bispecific CD33 and CD3 binding proteins

Single chain variable fragment CD3 binding proteins

Single domain serum albumin binding protein

Single chain variable fragment CD3 binding proteins

Single domain serum albumin binding protein

Bispecific CD33 and CD3 binding proteins

Trispecific binding proteins and methods of use

Bispecific CD33 and CD3 binding proteins

Patents Applicationslast 30 patents

SINGLE CHAIN VARIABLE FRAGMENT CD3 BINDING PROTEINS

ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF

SEPARATION MOIETIES AND METHODS OF USE THEREOF

SINGLE DOMAIN SERUM ALBUMIN BINDING PROTEIN

ACTIVATABLE INTERLEUKIN 12 POLYPEPTIDES AND METHODS OF USE THEREOF

SEPARATION MOIETIES AND METHODS OF USE THEREOF

ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF

ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF

TRISPECIFIC BINDING PROTEINS AND METHODS OF USE

SEPARATION MOIETIES AND METHODS OF USE THEREOF

Methods of Using Bispecific CD33 and CD3 Binding Proteins

Bispecific CD33 and CD3 Binding Proteins

ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF

ACTIVATABLE INTERLEUKIN 12 POLYPEPTIDES AND METHODS OF USE THEREOF

SINGLE CHAIN VARIABLE FRAGMENT CD3 BINDING PROTEINS

COMPOSITIONS AND METHODS FOR ADOPTIVE CELL THERAPIES

ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF

ACTIVATABLE INTERLEUKIN 12 POLYPEPTIDES AND METHODS OF USE THEREOF

INNATE IMMUNE CELL TRISPECIFIC BINDING PROTEINS AND METHODS OF USE

SINGLE DOMAIN SERUM ALBUMIN BINDING PROTEIN

Bispecific CD33 and CD3 Binding Proteins

METHODS OF USING BISPECIFIC CD33 AND CD3 BINDING PROTEINS

INDUCIBLE BINDING PROTEINS AND METHODS OF USE

SINGLE DOMAIN SERUM ALBUMIN BINDING PROTEIN

SINGLE CHAIN VARIABLE FRAGMENT CD3 BINDING PROTEINS

SINGLE CHAIN VARIABLE FRAGMENT CD3 BINDING PROTEINS

SINGLE DOMAIN SERUM ALBUMIN BINDING PROTEIN

TRISPECIFIC BINDING PROTEINS AND METHODS OF USE

TRISPECIFIC BINDING PROTEINS AND METHODS OF USE

Bispecific CD33 and CD3 Binding Proteins